Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors

doi:10.5306/wjco.v12.i7.544

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6739)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

390

WORD

221

HTML

3196

Figures (1-3)

380

Sum=4187

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

415

Download

855

Sum=1270

Publishing Process of This Article

Item

Count

Browse

350

Download

932

Sum=1282

Jul 24, 2021 (publication date) through Jan 22, 2025

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Jul 24, 2021; 12(7): 544-556
Published online Jul 24, 2021. doi: 10.5306/wjco.v12.i7.544

Full Size Figure Download Figure

Figure 3 Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors.

Citation: Imyanitov E, Sokolenko A. Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors. World J Clin Oncol 2021; 12(7): 544-556
URL: https://www.wjgnet.com/2218-4333/full/v12/i7/544.htm
DOI: https://dx.doi.org/10.5306/wjco.v12.i7.544